Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Faculty Opinions recommendation of Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. — George Perry | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Faculty Opinions recommendation of Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model.
Shared by
George Perry
Faculty Opinions recommendation of Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model.
Dataset
en
Authors
George Perry
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Dataset
Faculty Opinions recommendation of Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.
George Perry
Dataset
Faculty Opinions recommendation of Testing the amyloid toxicity hypothesis of Alzheimer's disease in transgenic Caenorhabditis elegans model.
George Perry
Dataset
Faculty Opinions recommendation of Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.
George Perry
Dataset
Faculty Opinions recommendation of Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model.
George Perry
Dataset
Faculty Opinions recommendation of A copper-binding site in the cytoplasmic domain of BACE1 identifies a possible link to metal homoeostasis and oxidative stress in Alzheimer's disease.
George Perry
Discussion(0)
No comments yet. Be the first to comment.